Media release of the HOCHDORF Group: Closing of the sale of Pharmalys Laboratories SA

Closing of the sale of the Pharmalys stake to Pharmalys Invest Holding

Hochdorf, 13 December 2019 -With all pre-conditions met for the sale of the 51% shares in companies of the Pharmalys Group to Pharmalys Invest Holding, the closing has been completed today. The HOCHDORF Group is thus completing an important step towards financial recovery and increasing its strategic flexibility.

Contact: Dr Christoph Hug, Head of Corporate Communications HOCHDORF-Group,

Phone: +41 (0)41 914 65 62 / Mobile: +41 (0)79 859 19 23, christoph.hug@hochdorf.com.

The HOCHDORF Group, headquartered in Hochdorf, generated consolidated net sales of CHF 561.0 million in 2018. It is one of Switzerland's leading food companies and had 694 employees as of 31.12.2018. Made from natural raw materials such as milk, wheat germ and oilseeds, HOCHDORF products have been contributing to the health and well-being of babies and seniors since 1895. Its customers include the food industry as well as wholesalers and retailers. The products are sold in over 90 countries. The shares are traded on the SIX Swiss Exchange in Zurich (ISIN CH0024666528).

Attachments

  • Original document
  • Permalink

Disclaimer

HOCHDORF Holding AG published this content on 13 December 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 December 2019 20:50:01 UTC